Ervin Investment Management, LLC Pfizer Inc Transaction History

Ervin Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $31,640 - $36,984	-986 Reduced 13.67%	6,228 $206,000
Q1 2023 Apr 14, 2023	SELL	$39.39 - $51.28 $47,268 - $61,536	-1,200 Reduced 14.26%	7,214 $294,000
Q4 2022 Apr 14, 2023	BUY	$41.75 - $54.5 $50,100 - $65,400	1,200 Added 16.63%	8,414 $431,000
Q2 2022 Apr 14, 2023	SELL	$46.53 - $55.17 $23,265 - $27,585	-500 Reduced 5.61%	8,414 $441,000
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $23,265 - $27,585	-500 Reduced 5.61%	8,414 $429,000
Q1 2022 Apr 14, 2023	BUY	$45.75 - $56.69 $77,775 - $96,373	1,700 Added 23.57%	8,914 $461,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $368,326 - $545,982	8,914 New	8,914 $526,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ervin Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ervin Investment Management, LLC with notifications on news.